Skip to main content
Quest Diagnostics

Optimal Growth Hormone Response despite Low Insulin-Like Growth Factor-1: Clinical Picture of an A67T IGF-1 Variant

ENDO2024

Boston, MA, June 1-4, 2024

Poster presentation: Optimal Growth Hormone Response despite Low Insulin-Like Growth Factor-1: Clinical Picture of an A67T IGF-1 Variant

Authors: Bomberg EM, Wu Z, Motorykin I, Torkelson J, Schmitz N, Drilling A, McPhaul MJ, Miller BS

Specialty: Endocrinology, Cardiology, Cardiovascular disease

Related content

Audio Podcast
Laboratory Testing for the Diagnosis and Management of Thyroid Disorders
On-Demand Webinar
Innovative Solutions: LC-MS/MS
Publication
Detection Rate of IGF-1 Variants and Their Implication to Protein Binding: Study of Over 240,000 Patients
Publication
Isotopic Peak Index, Relative Retention Time, and Tandem MS for Automated High Throughput IGF-1 Variants Identification in a Clinical Laboratory

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.